drugset / Trial / NCT07565792

Study of Food Effects of VV913 Capsules in Chinese Healthy Volunteers

NCT07565792 ↗

Phase 1 Recruiting 12 enrolled Vigonvita Life Sciences
RandomizedCrossoverOpen-labelTreatment

Summary

This study is a single-center, randomized, open label, 3×3 crossover design to assess the high-fat meal and the standard meal effects on PK of a single oral dose of VV913 in healthy adult volunteers.

Timeline

Start
2026-05-11
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject VV913 Unknown 5 mg Oral

Indications

No indication recorded.